Early use of antivirals linked to reduced risk of long COVID - CIDRAP

Retrieved on: 2024-06-04 15:37:44

Tags for this article:

COVID-19 drug development

Nirmatrelvir/ritonavir

Molnupiravir

Antiviral drug

COVID-19 drug repurposing research

Treatment and management of COVID-19

Click the tags to see associated articles and topics

Early use of antivirals linked to reduced risk of long COVID - CIDRAP. View article details on hiswai:

Excerpt

Overall early oral antiviral drugs reduced long-COVID risk 23% (risk ratio [RR] 0.77; 95% confidence interval [CI], 0.68 to 0.88), regardless of age ...

Article found on: www.cidrap.umn.edu

View Original Article